Sonoma Pharmaceuticals (SNOA) Amortization of Deferred Charges (2010 - 2011)

Sonoma Pharmaceuticals' (SNOA) quarterly Amortization of Deferred Charges came in at $128000.0 in Q4 2011, up 197.67% year-on-year from $43000.0 in Q4 2010, and up 9.4% quarter-over-quarter from $117000.0 in Q3 2011.

Sonoma Pharmaceuticals (SNOA) Amortization of Deferred Charges (2010 - 2011) Analysis & Trends

Sonoma Pharmaceuticals' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $128000.0 for Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.33 Bn 87.46 Bn -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.63 Bn 23.57 Bn 4.39 Bn
5 United Therapeutics 23.12 Bn 20.96 Bn 648.10 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn -
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn
10 Sonoma Pharmaceuticals 1.92 Mn -479,240.02 2.18 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 128,000.00
Dec 31, 2011 128,000.00
Sep 30, 2011 117,000.00
Sep 30, 2011 117,000.00
Jun 30, 2011 58,000.00
Jun 30, 2011 58,000.00
Dec 31, 2010 43,000.00
Dec 31, 2010 43,000.00
Sep 30, 2010 36,000.00
Sep 30, 2010 36,000.00
Jun 30, 2010 24,000.00
Jun 30, 2010 24,000.00